Is a complete SABS research report available?

No complete published report is available for SAB Biotherapeutics, Inc. (SABS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · USD

$3.19

+0.12 (+3.9%)· Recorded snapshot

Market cap	290.2M
Net income (ttm)	-21.8M
EPS (ttm)	-$1.56
Shares out	91M
Volume	300,016
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -21.8M
EPS (ttm): -$1.56
Market cap: 290.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001833214
Company name	SAB Biotherapeutics, Inc.
Country	United States
Country code	US
CUSIP number	78397T202
Earnings date	2026-11-12
Earnings time	amc
Employees	86
Employees change	23
Employees growth	36.51%
Enterprise value	$192.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US78397T2024
Last 10-K release date	2026-03-09
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2024-01-05
Last stock split type	Reverse
Market cap	$290.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$3.19
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	SABS
U.S. state	Florida
Website	https://www.sab.bio

Metric

Value

Amount currency

USD

CIK code

0001833214

Company name

SAB Biotherapeutics, Inc.

Country

United States

Country code

CUSIP number

78397T202

Earnings date

2026-11-12

Earnings time

amc

Employees

Employees change

Employees growth

36.51%

Enterprise value

$192.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US78397T2024

Last 10-K release date

2026-03-09

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2024-01-05

Last stock split type

Reverse

Market cap

$290.2M

Market cap category

Micro-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$3.19

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

SABS

U.S. state

Florida

Website

https://www.sab.bio

Metric	Value
Earnings yield	-48.78%
FCF / EV yield	-30.23%
FCF yield	-19.98%
P/B ratio	1.19x
Price / tangible book value	1.34x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-48.78%

FCF / EV yield

-30.23%

FCF yield

-19.98%

P/B ratio

1.19x

Price / tangible book value

1.34x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-253,346
Profitable years	1
ROA	-33.46%
ROA (5Y)	-28.98%
ROCE	-31.71%
ROE	-11.27%
ROE (5Y)	-52.1%
ROIC	-37.67%

Metric

Value

Profit per employee

$-253,346

Profitable years

ROA

-33.46%

ROA (5Y)

-28.98%

ROCE

-31.71%

ROE

-11.27%

ROE (5Y)

-52.1%

ROIC

-37.67%

Metric	Value
EPS growth quarters	4
EPS growth years	2
Net income growth years	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-3.5M
Depreciation and amortization	$3.1M
EBIT	$-71.8M
EBITDA	$-68.7M
EPS	$-1.56
FCF per share	$-0.63
Financing cash flow	$260.9M
Free cash flow	$-57.4M
Free cash flow minus SBC	$-74.1M
Gross profit	$-48.3M
Investing cash flow	$-202.1M
Net borrowing	$-148,412
Net cash flow	$4.6M
Net income	$-21.8M
Operating cash flow minus SBC	$-70.6M
Operating income	$-71.8M
Stock-based compensation	$16.7M

Metric

Value

Capital expenditures

$-3.5M

Depreciation and amortization

$3.1M

EBIT

$-71.8M

EBITDA

$-68.7M

EPS

$-1.56

FCF per share

$-0.63

Financing cash flow

$260.9M

Free cash flow

$-57.4M

Free cash flow minus SBC

$-74.1M

Gross profit

$-48.3M

Investing cash flow

$-202.1M

Net borrowing

$-148,412

Net cash flow

$4.6M

Net income

$-21.8M

Operating cash flow minus SBC

$-70.6M

Operating income

$-71.8M

Stock-based compensation

$16.7M

Metric	Value
Book value per share	$2.57
Debt / equity	0.02
Interest coverage	-310.04
Long-term assets	$130.3M
Long-term liabilities	$11.7M
Net cash (debt)	$97.5M
Net cash / market cap	33.91%
Net debt / equity	-0.45
Piotroski F-Score	1
Property, plant and equipment	$19.6M
Shareholders' equity	$214.8M
Tangible book value	$214.8M
Tangible book value per share	$2.57
Total assets	$238.2M
Total cash	$102.6M
Total debt	$5.1M
Total liabilities	$23.4M
WACC	7.39%

Metric

Value

Book value per share

$2.57

Debt / equity

0.02

Interest coverage

-310.04

Long-term assets

$130.3M

Long-term liabilities

$11.7M

Net cash (debt)

$97.5M

Net cash / market cap

33.91%

Net debt / equity

-0.45

Piotroski F-Score

Property, plant and equipment

$19.6M

Shareholders' equity

$214.8M

Tangible book value

$214.8M

Tangible book value per share

$2.57

Total assets

$238.2M

Total cash

$102.6M

Total debt

$5.1M

Total liabilities

$23.4M

WACC

7.39%

Metric	Value
Current assets	$107.9M
Current liabilities	$11.7M
Current ratio	9.22
Net working capital	$-5.8M
Quick ratio	8.93
Working capital	$96.2M

Metric

Value

Current assets

$107.9M

Current liabilities

$11.7M

Current ratio

9.22

Net working capital

$-5.8M

Quick ratio

8.93

Working capital

$96.2M

Metric	Value
Buyback yield / dilution	-417.54%
Dividend yield	0%
Shareholder yield	-417.54%

Metric

Value

Buyback yield / dilution

-417.54%

Dividend yield

Shareholder yield

-417.54%

Metric	Value
150-day SMA	$3.57
1D price change	3.91%
1M price change	-3.19%
1M total return	-3.19%
1W price change	10.59%
1W total return	10.59%
1Y price change	5.12%
1Y return CAGR	5.12%
1Y total return	5.12%
20-day SMA	$2.86
200-day SMA	$3.69
3M price change	-7.41%
3M total return	-7.41%
3Y price change	-67.5%
3Y return CAGR	-31.24%
3Y total return	-67.5%
50-day SMA	$3.28
50-day SMA vs 200-day SMA	50under200
52-week high	$5.15
52-week high date	2026-03-12
52-week low	$2.44
52-week low date	2026-10-19
5Y price change	-96.04%
5Y return CAGR	-47.59%
5Y total return	-96.04%
6M price change	-8.21%
6M total return	-8.21%
All-time high	$129.00
All-time high date	2021-10-22
All-time low	$1.00
All-time low date	2025-04-04
Average true range (ATR)	$0.21
Average volume	661K
Beta (1Y)	0.85
Beta (2Y)	1.02
Beta (5Y)	0.58
Change from 52-week high	-38.06%
Change from 52-week low	30.74%
Change from all-time high	-97.53%
Change from all-time low	218.5%
Change from open	1.59%
Day's gap	2.28%
Dollar volume	$957,051
High price	$3.20
Low price	$3.12
Monthly RSI	36.78
Open price	$3.14
Position in 52-week range	88.24%
Premarket change	0%
Premarket close	$3.07
Premarket price	$3.07
Premarket volume	899
Previous close	$3.07
Price vs 150-day SMA	-10.86%
Price vs 20-day SMA	11.44%
Price vs 200-day SMA	-13.62%
Price vs 50-day SMA	-2.78%
Relative volume	0.45
RSI	55.79
Sharpe ratio	0.32
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	-0.11
Sortino ratio	0.6
Sortino ratio (3Y)	0.14
Sortino ratio (5Y)	-0.13
Volume	300K
Weekly RSI	46.41
YTD price change	-14.84%
YTD total return	-14.84%

Metric

Value

150-day SMA

$3.57

1D price change

3.91%

1M price change

-3.19%

1M total return

-3.19%

1W price change

10.59%

1W total return

10.59%

1Y price change

5.12%

1Y return CAGR

5.12%

1Y total return

5.12%

20-day SMA

$2.86

200-day SMA

$3.69

3M price change

-7.41%

3M total return

-7.41%

3Y price change

-67.5%

3Y return CAGR

-31.24%

3Y total return

-67.5%

50-day SMA

$3.28

50-day SMA vs 200-day SMA

50under200

52-week high

$5.15

52-week high date

2026-03-12

52-week low

$2.44

52-week low date

2026-10-19

5Y price change

-96.04%

5Y return CAGR

-47.59%

5Y total return

-96.04%

6M price change

-8.21%

6M total return

-8.21%

All-time high

$129.00

All-time high date

2021-10-22

All-time low

$1.00

All-time low date

2025-04-04

Average true range (ATR)

$0.21

Average volume

661K

Beta (1Y)

0.85

Beta (2Y)

1.02

Beta (5Y)

0.58

Change from 52-week high

-38.06%

Change from 52-week low

30.74%

Change from all-time high

-97.53%

Change from all-time low

218.5%

Change from open

1.59%

Day's gap

2.28%

Dollar volume

$957,051

High price

$3.20

Low price

$3.12

Monthly RSI

36.78

Open price

$3.14

Position in 52-week range

88.24%

Premarket change

Premarket close

$3.07

Premarket price

$3.07

Premarket volume

899

Previous close

$3.07

Price vs 150-day SMA

-10.86%

Price vs 20-day SMA

11.44%

Price vs 200-day SMA

-13.62%

Price vs 50-day SMA

-2.78%

Relative volume

0.45

RSI

55.79

Sharpe ratio

0.32

Sharpe ratio (3Y)

0.05

Sharpe ratio (5Y)

-0.11

Sortino ratio

0.6

Sortino ratio (3Y)

0.14

Sortino ratio (5Y)

-0.13

Volume

300K

Weekly RSI

46.41

YTD price change

-14.84%

YTD total return

-14.84%

Metric	Value
Float	62M
Float percentage	68.19%
Shares change (QoQ)	48.91%
Shares change (YoY)	417.54%
Shares held by insiders	0.65%
Shares held by institutions	45.12%
Shares outstanding	91M
Short % of float	6.92%
Short % of shares	4.72%
Short ratio	7.6 days

Metric

Value

Float

62M

Float percentage

68.19%

Shares change (QoQ)

48.91%

Shares change (YoY)

417.54%

Shares held by insiders

0.65%

Shares held by institutions

45.12%

Shares outstanding

91M

Short % of float

6.92%

Short % of shares

4.72%

Short ratio

7.6 days

SAB Biotherapeutics, Inc. (SABS)

Price

Financial snapshot

Fair-value bridge

Latest news · SABS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SABS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SABS

Frequently asked questions